Page last updated: 2024-09-02

tadalafil and tryptoline

tadalafil has been researched along with tryptoline in 2 studies

Compound Research Comparison

Studies
(tadalafil)
Trials
(tadalafil)
Recent Studies (post-2010)
(tadalafil)
Studies
(tryptoline)
Trials
(tryptoline)
Recent Studies (post-2010) (tryptoline)
1,7423921,089222169

Protein Interaction Comparison

ProteinTaxonomytadalafil (IC50)tryptoline (IC50)
VifHuman immunodeficiency virus 184.25
DNA dC->dU-editing enzyme APOBEC-3G isoform 1Homo sapiens (human)84.25

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bischoff-Kont, I; Chaikuad, A; Faudone, G; Fürst, R; Heering, J; Kaiser, A; Knapp, S; Merk, D; Rachor, L; Willems, S; Zhubi, R1
Abadi, AH; Ahmed, NS; Gary, BD; Laufer, S; Piazza, GA; Tinsley, HN1

Other Studies

2 other study(ies) available for tadalafil and tryptoline

ArticleYear
Propranolol Activates the Orphan Nuclear Receptor TLX to Counteract Proliferation and Migration of Glioblastoma Cells.
    Journal of medicinal chemistry, 2021, 06-24, Volume: 64, Issue:12

    Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Glioblastoma; HEK293 Cells; Humans; Molecular Structure; Orphan Nuclear Receptors; Propranolol; Receptors, Cytoplasmic and Nuclear; Structure-Activity Relationship

2021
Design, synthesis and structure-activity relationship of functionalized tetrahydro-β-carboline derivatives as novel PDE5 inhibitors.
    Archiv der Pharmazie, 2011, Volume: 344, Issue:3

    Topics: Carbolines; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Design; Humans; Inhibitory Concentration 50; Phosphodiesterase 5 Inhibitors; Structure-Activity Relationship; Tadalafil

2011